Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Vaccinex, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −5 vs. Q2 2022
- Shares held
- 4.61M
- −29.4K (−0.6%) vs. Q2 2022
- Total value
- $2.28M
- −$2.75M (−54.6%) vs. Q2 2022
- New holders
- 0
- 11 more added
- Sold out
- 5
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VCNX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $45 |
| Q3 2024 | 12 | $1.14M |
| Q2 2024 | 11 | $1.81M |
| Q1 2024 | 12 | $2.39M |
| Q4 2023 | 18 | $1.07M |
| Q3 2023 | 19 | $2.92M |
| Q2 2023 | 23 | $994.8K |
| Q1 2023 | 24 | $1.10M |
| Q4 2022 | 25 | $3.12M |
| Q3 2022 | 22 | $2.28M |
| Q2 2022 | 27 | $5.03M |
| Q1 2022 | 25 | $5.49M |
| Q4 2021 | 21 | $1.66M |
| Q3 2021 | 23 | $3.36M |
| Q2 2021 | 28 | $4.54M |
| Q1 2021 | 33 | $2.79M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vaccinex, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 184 | $0 | 0.00% | −16−8.0% | Reduced |
| Morgan Stanley | 364 | $0 | 0.00% | +64+21.3% | Added |
| Advisor Group Holdings, Inc. | 3,600 | $2.00K | 0.00% | +100+2.9% | Added |
| Royal Bank of Canada | 5,419 | $3.00K | 0.00% | +266+5.2% | Added |
| Virtu Financial LLC | 10,370 | $5.00K | 0.00% | −542−5.0% | Reduced |
| Creative Planning | 11,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Moors & Cabot, Inc. | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Vectors Research Management, LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| HNP Capital LLC | 10,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 20,971 | $10.0K | 0.00% | +15,600+290.4% | Added |
| Northern Trust Corp | 23,369 | $12.0K | 0.00% | +6,219+36.3% | Added |
| BlackRock Inc. | 49,517 | $25.0K | 0.00% | −13,700−21.7% | Reduced |
| Simplex Trading, LLC | 66,544 | $32.0K | 0.00% | +21,896+49.0% | Added |
| Millennium Management LLC | 70,811 | $35.0K | 0.00% | −80,855−53.3% | Reduced |
| State Street Corp | 71,400 | $35.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 87,700 | $43.0K | 0.00% | +59,561+211.7% | Added |
| Citadel Advisors LLC | 100,268 | $50.0K | 0.00% | +42,364+73.2% | Added |
| Geode Capital Management, LLC | 250,880 | $124.0K | 0.00% | +1,887+0.8% | Added |
| Telemetry Investments, L.L.C. | 490,000 | $243.0K | 0.40% | +1,000+0.2% | Added |
| Worth Venture Partners, LLC | 507,795 | $251.0K | 0.16% | 00.0% | Unchanged |
| Vanguard Group Inc | 732,165 | $363.0K | 0.00% | +4,900+0.7% | Added |
| AIGH Capital Management LLC | 2,081,801 | $1.03M | 0.41% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −54,651−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −22,472−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Financial Connections Group, Inc. | 0 | $0 | 0.00% | −4,044−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |